Regis Healthcare (ASX:REG) carries a consensus analyst rating of Buy. Of the 6 analyst recommendations recorded, 2 are Buy or equivalent, 4 are Hold and 0 are Sell or equivalent. The mean price target is A$6.08, with targets ranging from A$5.00 to A$7.40, against …
For investors following Sonic Healthcare (ASX:SHL), the key valuation question is how the currentMarket Pricecompares with analyst expectations for the diagnostics group. At AUD 18.70 per share, the stock sits below the mean analyst target of AUD 22.38, equivalent to approximately 19.68% implied upside. …
Key HighlightsCochlear Limited (ASX:COH) shares are priced at AUD 129.00, compared with a mean analyst target of AUD 138.17.The mean target represents 7.11% implied upside, while the consensus recommendation is Hold.The target range extends from AUD 117.00 to AUD 165.00, with 16 recommendations in …
Investors took the deal calmly. CSL shares edged higher on Monday, with one market report putting the gain at just under 1 per cent and the stock changing hands around $175, while the S&P/ASX 200 finished only marginally in positive territory after giving up …
For context, the S&P/ASX 200 Info Tech [XIJ] (INDEXASX: XIJ) stood at 1,684.00, down 2.90% (−50.30 points) today as of 6 Oct, and is down 42.73% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) today, and is …
Resmed develops and sells devices, masks, accessories and software for sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions, withRevenuefrom devices, masks and accessories, and software, including residential care software. It is headquartered in San Diego and describes its products as AI-powered digital …
Sigma distributes pharmaceutical and health products to pharmacies and operates the Chemist Warehouse network, earning wholesale and retailRevenuein Australia and internationally. It states that its network is approaching 1,000 pharmacies globally. During FY26 it added 24 Chemist Warehouse branded stores to the Australian network, …
Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …
Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …
Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …